From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

HIV and Hepatitis Co-infections

As HIV treatment evolves and simplified treatment regimens become more common, understanding the implications of viral hepatitis co-infection is increasingly important. This webinar will provide a practical update on hepatitis B, hepatitis D and hepatitis C in people living with HIV, with a particular focus on treatment decision-making and avoiding unintended consequences when modifying antiretroviral […]

Hepatitis B Prescriber Update

This interactive 90-minute training provides medical and nurse practitioners who prescribe HBV antiviral medications an opportunity to apply their knowledge and skills to practical case studies. Case scenarios are developed by ASHM clinical advisors or local experts to meet the identified learning needs of medical practitioners, which vary from each State and Territory. Attendees are […]

Opportunities for Sexual Health in AOD Settings: A Whole‑of‑Service Response to Syphilis

Syphilis rates have tripled in Australia over the past decade, highlighting the urgent need for greater awareness, screening and early intervention across a range of health and community settings. People accessing alcohol and other drug (AOD) services often face additional barriers to care and are at increased risk of sexually transmissible infections (STIs), including syphilis. Staff working in these […]

Hepatitis C in AOD Settings: Practical Strategies and Service-Level Solutions

People accessing alcohol and other drug (AOD) services are disproportionately affected by hepatitis C, yet many continue to face barriers to testing, treatment and ongoing care. AOD services and needle and syringe programs are uniquely positioned to change this, playing a critical role in Australia’s hepatitis C elimination efforts. Join colleagues from across the AOD and health […]

Advanced Gender Affirming Hormone Therapy – Expression of Interest

This is an Expression of Interest page. By clicking “Register Now” your name will be added to a wait list. You will be notified to register via email when a session becomes available in your state of residence or practice.